Day: August 7, 2024

Greystone Housing Impact Investors Reports Second Quarter 2024 Financial Results

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

OMAHA, Neb., Aug. 07, 2024 (GLOBE NEWSWIRE) — On August 7, 2024, Greystone Housing Impact Investors LP (NYSE: GHI) (the “Partnership”) announced financial results for the three months ended June 30, 2024. Financial Highlights The Partnership reported the following results as of and for the three months ended June 30, 2024: Net income of $0.19 per Beneficial Unit Certificate (“BUC”), basic and diluted Cash Available for Distribution (“CAD”) of $0.27 per BUC Total assets of $1.53 billion Total Mortgage Revenue Bond (“MRB”) and Governmental Issuer Loan (“GIL”) investments of $1.22 billion The Partnership reported the following results for the six months ended June 30, 2024: Net income of $0.61 per BUC, basic and diluted CAD of $0.50 per BUC In June 2024, the Partnership announced that the Board of Managers of Greystone AF Manager...

Continue reading

Lofty Acquires Real Estate CRM Solution Firepoint

Written by Customer Service on . Posted in Mergers And Acquisitions.

Dedicated Lofty customer success team helps seamlessly transition new agents to award-winning platform, minimizing disruption to business PHOENIX, Aug. 07, 2024 (GLOBE NEWSWIRE) — Award-winning real estate technology innovator Lofty today announced it has acquired Firepoint, a real estate CRM solution designed by top team leaders and agents. As the company’s strategy shifted and plans were made to refocus development efforts in other areas, Firepoint CEO Dave Crumby sought a top industry partner to help transition his customers to a new platform. Specifically, an innovative end-to-end platform, purpose built for today’s real estate professionals. Heralded for its intuitive interface and robust features powered by AI, Lofty was the only choice. In addition, Dave was committed to ensuring continuity for his team of agents during...

Continue reading

PetIQ, Inc. Reports Second Quarter 2024 Financial Results

Written by Customer Service on . Posted in Public Companies.

Generates Record Second Quarter 2024 Net Sales and Net IncomeRecord Adjusted EBITDA of $39.0 Million Exceeds Company’s Second Quarter 2024 GuidancePetIQ and Bansk Group Sign Definitive Merger Agreement EAGLE, Idaho, Aug. 07, 2024 (GLOBE NEWSWIRE) — PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication, product and wellness company, today reported financial results for the second quarter and six months ended June 30, 2024. Cord Christensen, PetIQ’s Founder and CEO, commented, “We are very pleased to report another quarter of record financial results. The strength of PetIQ’s brands fueled second quarter profitability that exceeded our expectations. We believe these results demonstrate the resilience of the pet medication and health and wellness categories in which we compete. The strategic marketing...

Continue reading

PetIQ, Inc. Enters into Definitive Agreement to be Acquired by Bansk Group

Written by Customer Service on . Posted in Mergers And Acquisitions.

PetIQ Stockholders to Receive $31.00 Per Share in an All-Cash Transaction Valued at Approximately $1.5 Billion EAGLE, Idaho, and NEW YORK, New York, Aug. 07, 2024 (GLOBE NEWSWIRE) — PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication, health and wellness company, and Bansk Group (“Bansk”), a consumer-focused private investment firm dedicated to building distinctive consumer brands, today announced that PetIQ entered into a definitive agreement (the “Agreement”) pursuant to which Bansk Group will acquire all of the outstanding shares of PetIQ’s common stock for $31.00 per share, in an all-cash transaction valued at approximately $1.5 billion. PetIQ’s Board of Directors (the “Board”) has approved the Agreement, which represents a premium of approximately 41% to the 30-day volume-weighted average stock...

Continue reading

Conduent Reports Second Quarter 2024 Financial Results

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

Key Q2 2024 Highlights Revenue: $828M Adj. Revenue(1): $811M Pre-tax Income: $300M Adj. EBITDA Margin(1): 3.6% New Business Signings ACV(2): $142M Net ARR Activity Metric(2) (TTM): $(49)M FLORHAM PARK, N.J., Aug. 07, 2024 (GLOBE NEWSWIRE) — Conduent (NASDAQ: CNDT), a global technology-led business process solutions and services company, today announced its second quarter 2024 financial results. Cliff Skelton, Conduent President and Chief Executive Officer stated, “We are pleased to report that our Adjusted Revenue and Adjusted EBITDA exceeded expectations, with upside from here. Meanwhile, as anticipated, Q2 represented the low point in our previously communicated growth trajectory. Commercial sales were stronger on both a year-over-year and sequential basis and although Government sales is off to a slower than anticipated start...

Continue reading

MannKind Corporation Reports 2024 Second Quarter Financial Results: Provides Clinical Development Update

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

Conference Call to Begin Today at 9:00 a.m. (ET) 2Q 2024 Total revenues of $72M; +49% vs. 2Q 2023 YTD 2024 Total revenues of $139M; +55% vs. YTD 2023 YTD 2024 Net income of $9 million; Non-GAAP net income of $29 million Advances two orphan lung programs to human studies MNKD-101 Phase 3 clinical trial activities initiated MNKD-201 Phase 1 clinical trial on schedule to read out 4Q 2024 DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Aug. 07, 2024 (GLOBE NEWSWIRE) — MannKind Corporation (Nasdaq: MNKD) today reported financial results for the quarter ended June 30, 2024. “We achieved our ninth consecutive quarter of revenue growth and are approaching an annual revenue run rate of over $275 million based on the first half of 2024,” said Michael Castagna, PharmD, Chief Executive Officer of MannKind Corporation. “We are excited about...

Continue reading

NewAmsterdam Pharma Provides Corporate Update and Reports Second Quarter Financial Results

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

— Reported positive topline data from pivotal Phase 3 BROOKLYN trial evaluating obicetrapib in patients with HeFH; achieved primary endpoint of LS mean reduction in LDL-C versus placebo, as well as statistically significant reductions in other biomarkers, with safety results comparable to placebo – — Extended US IP protection into 2043 with a new composition of matter patent — — On-track to report topline data from pivotal Phase 3 BROADWAY trial in 4Q 2024 – — Completed enrollment of pivotal Phase 3 TANDEM trial evaluating fixed-dose combination of obicetrapib and ezetimibe; topline data expected in 1Q 2025 — — Strong financial position; $430.7 million in cash — NAARDEN, the Netherlands and MIAMI, Aug. 07, 2024 (GLOBE NEWSWIRE) — NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or...

Continue reading

Intermex Reports Second Quarter Results

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

Company continues to generate strong earnings and margins, continued execution of omnichannel strategy Company to Host Conference Call Today at 9 a.m. ET MIAMI, Aug. 07, 2024 (GLOBE NEWSWIRE) — International Money Express, Inc. (NASDAQ: IMXI) (“Intermex” or the “Company”), one of the nation’s leading omnichannel money transfer services to Latin America and the Caribbean, today reported strong operating results for the second quarter of 2024. Financial performance highlights for the second quarter of 2024 compared with the same period last year are: Revenues of $171.5 million, an increase of 1.4%. Net income of $14.0 million, a decrease of 9.1%. Diluted EPS of $0.42 per share, same as the prior period. Adjusted Diluted EPS of $0.55 per share, an increase of 10.0%. Adjusted EBITDA of $31.1 million, an increase of 0.6%. Bob Lisy,...

Continue reading

Stryker declares an $0.80 per share quarterly dividend

Written by Customer Service on . Posted in Dividend Reports And Estimates.

Portage, Michigan, Aug. 07, 2024 (GLOBE NEWSWIRE) — Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.80 per share payable October 31, 2024 to shareholders of record at the close of business on September 30, 2024, representing an increase of 6.7% versus the prior year and unchanged from the previous quarter.  About Stryker Stryker is a global leader in medical technologies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in MedSurg, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 150 million patients annually. More information is available at www.stryker.com. Contacts For investor inquiries please contact:Jason...

Continue reading

Karat Packaging Board Declares Special Cash Dividend and Regular Quarterly Cash Dividend

Written by Customer Service on . Posted in Dividend Reports And Estimates.

CHINO, Calif., Aug. 07, 2024 (GLOBE NEWSWIRE) — Karat Packaging Inc. (Nasdaq: KRT) (the “Company” or “Karat”), a specialty distributor and manufacturer of disposable foodservice products and related items, today announced that its board of directors has approved payment of a regular quarterly cash dividend of $0.35 per share. The board also declared a special cash dividend of $0.15 per share on the Company’s common stock. Both dividends are payable on or about August 30, 2024, to shareholders of record at the close of business on August 21, 2024. “These distributions reflect Karat’s strong cash position and positive long-term outlook,” said Alan Yu, chief executive officer. “Our board remains committed to providing returns to our shareholders and to continually assess opportunities to enhance shareholder value.” About Karat Packaging...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.